Selectis Health (OTCMKTS:GBCS) versus Icon (NASDAQ:ICLR) Critical Comparison

Selectis Health (OTCMKTS:GBCS) and Icon (NASDAQ:ICLR) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Selectis Health and Icon, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Selectis Health	0	0	0	0	0.00
Icon	3	6	9	0	2.33

Icon has a consensus target price of $173.19, suggesting a potential downside of 1.06%. Given Icon’s stronger consensus rating and higher probable upside, analysts clearly believe Icon is more favorable than Selectis Health.

Institutional & Insider Ownership

95.6% of Icon shares are owned by institutional investors. 15.2% of Selectis Health shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Earnings and Valuation

This table compares Selectis Health and Icon”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Selectis Health	$41.44 million	0.39	-$1.02 million	($0.34)	-15.32
Icon	$8.25 billion	1.62	$229.34 million	$5.62	31.15

Icon has higher revenue and earnings than Selectis Health. Selectis Health is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Selectis Health has a beta of -1.07, indicating that its share price is 207% less volatile than the S&P 500. Comparatively, Icon has a beta of 1.22, indicating that its share price is 22% more volatile than the S&P 500.

Profitability

This table compares Selectis Health and Icon’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Selectis Health	-2.45%	N/A	-3.03%
Icon	5.35%	8.73%	4.96%

Summary

Icon beats Selectis Health on 14 of the 14 factors compared between the two stocks.

About Selectis Health

Selectis Health owns and/or operates healthcare facilities in Arkansas, Georgia, Ohio, and Oklahoma, providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services. Selectis focuses on building strategic relationships with local communities in which its partnership can improve the quality of care for facility residents. With its focused growth strategy, Selectis intends to deepen its American Southcentral and Southeastern market presence to better serve the aging population along a full continuum of care.

About Icon

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.